In order to improve the prognosis of pancreatic cancer, the development of methods for early detection of pancreatic cancer with a blood test is important. Working toward that goal, a research collaboration between Kumamoto University, Tohoku University and the National Cancer Center of Japan has discovered proteins in the blood which improve the detection of pancreatic cancer. When used in combination with conventional biomarkers, they enable the diagnosis of early stage pancreatic cancer, which was previously difficult. Read more . . .
Pancreatic cancer is one of the most lethal forms of cancer because early stage symptoms are relatively light, often resulting in it being discovered only after spreading to other organs.